secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2022-11-16T23:59:59+00:00
Accession:  0001005286-22-000080
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Landec Corp renames to Lifecore Biomedical; new Nasdaq ticker LFCR effective Nov 15
--------------------------------------------------------------------------------

- Name change from Landec Corporation to Lifecore Biomedical filed Nov 14, 2022; effective same day.
- Common stock ticker changes to LFCR on Nasdaq from LNDC, effective Nov 15, 2022.
- Corporate headquarters relocated to Chaska, MN; no change to CUSIP number.
- CEO James G. Hall and CFO John D. Morberg remain; board realigned for life sciences focus.
- No stockholder vote required; name change aligns with strategic pivot to CDMO business.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528622000080/0001005286-22-000080-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528622000080/lndc-20221114.htm
  HTML page:      https://secwatch.observer/filing/0001005286-22-000080

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer